AstraZeneca is Thursday's pick for IBD 50 Growth Stocks To Watch as the biopharmaceutical name is holding up relatively well in a declining market. AstraZeneca stock is nearing a buy point after ...

Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sutro Biopharma (STRO – Research Report) and ...

Novo Nordisk faces formidable challenges from Eli Lilly and new rivals, but its first-mover advantage and expanded ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

As the U.S. stock market faces a sell-off driven by concerns over tariffs and economic uncertainty, investors are increasingly looking for opportunities that can offer resilience and potential growth.

StockNews.com cut shares of Arbutus Biopharma (NASDAQ:ABUS – Free Report) from a hold rating to a sell rating in a research report released on Thursday morning. A number of other equities research ...

Arizona State Retirement System grew its holdings in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 1.1% in the 4th quarter, according to its most recent disclosure with the SEC. The ...